Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Reviews in the Neurosciences

Editor-in-Chief: Huston, Joseph P.

Editorial Board Member: Topic, Bianca / Adeli, Hojjat / Buzsaki, Gyorgy / Crawley, Jacqueline / Crow, Tim / Eichenbaum, Howard / Gold, Paul / Holsboer, Florian / Korth, Carsten / Lubec, Gert / McEwen, Bruce / Pan, Weihong / Pletnikov, Mikhail / Robbins, Trevor / Schnitzler, Alfons / Stevens, Charles / Steward, Oswald / Trojanowski, John

8 Issues per year


IMPACT FACTOR 2016: 2.546
5-year IMPACT FACTOR: 3.191

CiteScore 2016: 3.30

SCImago Journal Rank (SJR) 2016: 1.249
Source Normalized Impact per Paper (SNIP) 2016: 0.983

Online
ISSN
2191-0200
See all formats and pricing
More options …
Volume 23, Issue 1 (Feb 2012)

Issues

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

Chong Gao
  • Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Christian Hölscher / Yueze Liu
  • Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lin Li
  • Department of Physiology, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, 030001, China
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-12-21 | DOI: https://doi.org/10.1515/rns.2011.061

Abstract

As a constitutively active kinase, glycogen synthase kinase 3 (GSK3) is a kinase which regulates body metabolism by phosphorylation of glycogen synthase (GS) and other substrates. Considerable evidence suggests that GSK3 is involved in the common pathology underlying Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM). The overexpression or overactivation of GSK3 could induce a series of pathological changes, most of which are hallmarks of AD and T2DM. Therefore, GSK3 could be a novel target to treat these two age-dependent diseases. The inhibition of this kinase can prevent the aggregation of β-amyloid (Aβ) and hyperphosphorylation of tau protein. GSK3 inhibition can also be a promising strategy to ameliorate neurodegenerative developments. Its potential association with memory formation has been shown in electrophysiological and behavioral experiments. The neuroprotective effects of novel drugs developed to treat T2DM, glucagon-like peptide 1 (GLP-1) and its long-lasting analogs, have a possible link to GSK3 modification. Recent investigations of the interaction between the phosphatidylinositol 3 kinase (PI3K) signaling pathway and the protective effect of novel GPL-1 receptor agonist geniposide on PC12 cells support this theory.

Keywords: Alzheimer’s disease; β-amyloid (Aβ); glucagon-like peptide 1 (GLP-1); glycogen synthase kinase 3 (GSK3); neurofibrillary tangles (NFTs); type 2 diabetes mellitus (T2DM)

About the article

Corresponding author


Received: 2011-09-14

Accepted: 2011-12-21

Published Online: 2011-12-21

Published in Print: 2012-02-01


Citation Information: Reviews in the Neurosciences, ISSN (Online) 2191-0200, ISSN (Print) 0334-1763, DOI: https://doi.org/10.1515/rns.2011.061.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
YI-XIA ZHOU, LI-XIN SHI, HUA YANG, YI-GUO LONG, LU MENG, LI-SA LV, YANG ZHANG, HUAN YAO, LONG LI, and YAN-NI YU
Experimental and Therapeutic Medicine, 2016, Volume 11, Number 6, Page 2495
[2]
F. Marampon, C. Antinozzi, C. Corinaldesi, G. B. Vannelli, E. Sarchielli, S. Migliaccio, L. Di Luigi, A. Lenzi, and C. Crescioli
Endocrine, 2017
[3]
Susan Westfall, Nikita Lomis, Imen Kahouli, Si Yuan Dia, Surya Pratap Singh, and Satya Prakash
Cellular and Molecular Life Sciences, 2017
[4]
Qingjie Chen, Ran Mo, Ninghua Wu, Xin Zou, Cai Shi, Jing Gong, Jingbin Li, Ke Fang, Dingkun Wang, Deshen Yang, Kaifu Wang, and Juan Chen
Frontiers in Pharmacology, 2017, Volume 8
[5]
Valle Palomo, Daniel I. Perez, Carlos Roca, Cara Anderson, Natalia Rodríguez-Muela, Concepción Perez, Jose A. Morales-Garcia, Julio A. Reyes, Nuria E. Campillo, Ana M. Perez-Castillo, Lee L. Rubin, Lubov Timchenko, Carmen Gil, and Ana Martinez
Journal of Medicinal Chemistry, 2017, Volume 60, Number 12, Page 4983
[6]
Anisha S. Bhounsule, Lokesh Kumar Bhatt, Kedar S. Prabhavalkar, and Manisha Oza
Brain Research Bulletin, 2017, Volume 132, Page 28
[7]
Luisa Quesada-Romero, Karel Mena-Ulecia, William Tiznado, Julio Caballero, and Zhe Zhang
PLoS ONE, 2014, Volume 9, Number 7, Page e102212
[8]
Aderbal R. T. Silva, Ana Cecília Feio Santos, Jose M. Farfel, Lea T. Grinberg, Renata E. L. Ferretti, Antonio Hugo Jose Froes Marques Campos, Isabela Werneck Cunha, Maria Dirlei Begnami, Rafael M. Rocha, Dirce M. Carraro, Carlos Alberto de Bragança Pereira, Wilson Jacob-Filho, Helena Brentani, and Hoon Ryu
PLoS ONE, 2014, Volume 9, Number 6, Page e99897
[9]
Jinyue Hu, Guihua Wang, Xueting Liu, Lina Zhou, Manli Jiang, Li Yang, and Simona Stager
PLoS ONE, 2013, Volume 8, Number 10, Page e78832
[10]
Weijie Xu, Juanhong Liu, Delin Ma, Gang Yuan, Yan Lu, Yan Yang, and Cheng Hu
PLOS ONE, 2017, Volume 12, Number 2, Page e0172477
[11]
Adonis Sfera, Carolina Osorio, Luzmin Acosta Inderias, Victoria Parker, Amy I. Price, and Michael Cummings
Frontiers in Psychiatry, 2017, Volume 8
[12]
Luminita Crisan, Sorin Avram, and Liliana Pacureanu
Molecular Diversity, 2017, Volume 21, Number 2, Page 385
[13]
Badar ul Islam and Shams Tabrez
International Journal of Biological Macromolecules, 2017, Volume 97, Page 700
[14]
Gerd Birkenmeier, Nasr Y. A. Hemdan, Susanne Kurz, Marina Bigl, Philipp Pieroh, Tewodros Debebe, Martin Buchold, Rene Thieme, Gunnar Wichmann, Faramarz Dehghani, and Halvard Bönig
PLOS ONE, 2016, Volume 11, Number 8, Page e0161571
[15]
Mariana Eiras Borges, Alessandra Mussi Ribeiro, José Rodrigo Pauli, Luciana Mendonça Arantes, Eliete Luciano, Leandro Pereira de Moura, José Alexandre Curiacos de Almeida Leme, Alessandra Medeiros, Natália Oliveira Bertolini, Clarice Yoshiko Sibuya, and Ricardo José Gomes
Neuroscience Letters, 2017, Volume 639, Page 157
[16]
Yu Cao, Xingxing Jia, Yun Wei, Meixia Liu, Jiangang Liu, and Hao Li
Evidence-Based Complementary and Alternative Medicine, 2016, Volume 2016, Page 1
[17]
Roy Chun-Laam Ng, On-Yin Cheng, Min Jian, Jason Shing-Cheong Kwan, Philip Wing-Lok Ho, Kenneth King-Yip Cheng, Patrick Ka Kit Yeung, Lena Lei Zhou, Ruby Lai-Chong Hoo, Sookja Kim Chung, Aimin Xu, Karen Siu-Ling. Lam, and Koon Ho Chan
Molecular Neurodegeneration, 2016, Volume 11, Number 1
[18]
Valle Palomo and Ana Martinez
Expert Opinion on Therapeutic Patents, 2017, Volume 27, Number 6, Page 657
[19]
Chandra Sekhar Kuruva and P. Hemachandra Reddy
Drug Discovery Today, 2017, Volume 22, Number 2, Page 223
[20]
James A. McCubrey, Dariusz Rakus, Agnieszka Gizak, Linda S. Steelman, Steve L. Abrams, Kvin Lertpiriyapong, Timothy L. Fitzgerald, Li V. Yang, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Aurora Scalisi, Francesco Torino, Concettina Fenga, Luca M. Neri, Sandra Marmiroli, Lucio Cocco, and Alberto M. Martelli
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016, Volume 1863, Number 12, Page 2942
[21]
Lin He, Xuejie Li, Qun Wang, Qing Li, and Zelin Duan
Crustaceana, 2016, Volume 89, Number 5, Page 559
[22]
Lin Li, Juan Zhao, Ke Liu, Guang-lai Li, Yan-qing Han, and Yue-ze Liu
Neural Regeneration Research, 2015, Volume 10, Number 10, Page 1617
[23]
Hsin-Hua Li, Shi-Lung Lin, Chien-Ning Huang, Fung-Jou Lu, Pai-Yi Chiu, Wen-Nung Huang, Te-Jen Lai, and Chih-Li Lin
Journal of Alzheimer's Disease, 2016, Volume 50, Number 4, Page 1083
[24]
Ramesh Kandimalla and P. Hemachandra Reddy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016, Volume 1862, Number 4, Page 814
[25]
Yuan Qin, Yan-Huan He, Ning Hou, Gen-Shui Zhang, Yi Cai, Gui-Ping Zhang, Qing Xiao, Li-Shan He, Su-Juan Li, Quan Yi, and Jian-Dong Luo
Molecular and Cellular Endocrinology, 2016, Volume 423, Page 30
[26]
Weijie Xu, Yan Yang, Gang Yuan, Wenjun Zhu, Delin Ma, and Shuhong Hu
Journal of Investigative Medicine, 2015, Volume 63, Number 2, Page 267
[27]
Zhenzhen Liu, Tao Li, Ping Li, Nannan Wei, Zhiquan Zhao, Huimin Liang, Xinying Ji, Wenwu Chen, Mengzhou Xue, and Jianshe Wei
Oxidative Medicine and Cellular Longevity, 2015, Volume 2015, Page 1
[28]
Robert Linke, Ralph Pries, Michael Könnecke, Karl-Ludwig Bruchhage, Robert Böscke, Maximilian Gebhard, and Barbara Wollenberg
Annals of Allergy, Asthma & Immunology, 2013, Volume 110, Number 2, Page 101
[29]
Edna Grünblatt, Jasmin Bartl, Diana-Iulia Iuhos, Ana Knezovic, Vladimir Trkulja, Peter Riederer, Susanne Walitza, and Melita Salkovic-Petrisic
Journal of Molecular Psychiatry, 2015, Volume 3, Number 1
[30]
Mojtaba Golpich, Elham Amini, Fatemeh Hemmati, Norlinah Mohamed Ibrahim, Behrouz Rahmani, Zahurin Mohamed, Azman Ali Raymond, Leila Dargahi, Rasoul Ghasemi, and Abolhassan Ahmadiani
Pharmacological Research, 2015, Volume 97, Page 16
[31]
Prasanna Sivaprakasam, Xiaojun Han, Rita L. Civiello, Swanee Jacutin-Porte, Kevin Kish, Matt Pokross, Hal A. Lewis, Nazia Ahmed, Nicolas Szapiel, John A. Newitt, Eric T. Baldwin, Hong Xiao, Carol M. Krause, Hyunsoo Park, Michelle Nophsker, Jonathan S. Lippy, Catherine R. Burton, David R. Langley, John E. Macor, and Gene M. Dubowchik
Bioorganic & Medicinal Chemistry Letters, 2015, Volume 25, Number 9, Page 1856
[32]
Yili Wu, Philip T. T. Ly, and Weihong Song
Molecular Neurobiology, 2014, Volume 50, Number 3, Page 1085
[33]
Amira Zarrouk, Anne Vejux, John Mackrill, Yvonne O’Callaghan, Mohamed Hammami, Nora O’Brien, and Gérard Lizard
Ageing Research Reviews, 2014, Volume 18, Page 148
[34]
Samantha L. Goggin, Kevin K. Caldwell, Lee Anna Cunningham, and Andrea M. Allan
Toxicology Reports, 2014, Volume 1, Page 544
[35]
Juvenal A. Ríos, Pedro Cisternas, Marco Arrese, Salesa Barja, and Nibaldo C. Inestrosa
Progress in Neurobiology, 2014, Volume 121, Page 125
[36]
Kazuhiko Namekata, Atsuko Kimura, Kazuto Kawamura, Chikako Harada, and Takayuki Harada
Progress in Retinal and Eye Research, 2014, Volume 43, Page 1
[37]
Tatiana V. Lipina and John C. Roder
Neuroscience & Biobehavioral Reviews, 2014, Volume 45, Page 271
[38]
Eunyoung Lee, Ji-Eun Eom, Hye-Lin Kim, Kyung Hye Baek, Kyu-Yeon Jun, Hwa-Jung Kim, Minyung Lee, Inhee Mook-Jung, and Youngjoo Kwon
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013, Volume 1831, Number 4, Page 709
[39]
Tiago Silva, Joana Reis, José Teixeira, and Fernanda Borges
Ageing Research Reviews, 2014, Volume 15, Page 116
[40]
H.-Y. Cai, C. Hölscher, X.-H. Yue, S.-X. Zhang, X.-H. Wang, F. Qiao, W. Yang, and J.-S. Qi
Neuroscience, 2014, Volume 277, Page 6
[41]
[42]
Manuel Torres, Samantha L. Price, Maria A. Fiol-deRoque, Amaia Marcilla-Etxenike, Hasna Ahyayauch, Gwendolyn Barceló-Coblijn, Silvia Terés, Loukia Katsouri, Margarita Ordinas, David J. López, Maitane Ibarguren, Félix M. Goñi, Xavier Busquets, Javier Vitorica, Magdalena Sastre, and Pablo V. Escribá
Biochimica et Biophysica Acta (BBA) - Biomembranes, 2014, Volume 1838, Number 6, Page 1680
[44]
P. Hemachandra Reddy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, Volume 1832, Number 12, Page 1913
[45]
James A. McCubrey, Nicole M. Davis, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Jorg Basecke, Massimo Libra, Ferdinando Nicoletti, Lucio Cocco, Alberto M. Martelli, and Linda S. Steelman
Advances in Biological Regulation, 2014, Volume 54, Page 176
[47]
J A McCubrey, L S Steelman, F E Bertrand, N M Davis, S L Abrams, G Montalto, A B D'Assoro, M Libra, F Nicoletti, R Maestro, J Basecke, L Cocco, M Cervello, and A M Martelli
Leukemia, 2014, Volume 28, Number 1, Page 15
[48]
Marcos Emilio Frizzo
Medical Hypotheses, 2013, Volume 81, Number 3, Page 376
[49]
Jun Tang, Yijin Pei, and Guangji Zhou
Experimental Gerontology, 2013, Volume 48, Number 8, Page 744
[50]
Hongyan Li, Hyung Min Jeong, You Hee Choi, Sung Ho Lee, Hye Gwang Jeong, Tae Cheon Jeong, and Kwang Youl Lee
Biochemical and Biophysical Research Communications, 2013, Volume 434, Number 3, Page 653
[51]
Jim R. Fadel, Corinne G. Jolivalt, and Lawrence P. Reagan
Ageing Research Reviews, 2013, Volume 12, Number 3, Page 764
[52]
Yasuko Kitagishi, Mayumi Kobayashi, Kanae Kikuta, and Satoru Matsuda
Depression Research and Treatment, 2012, Volume 2012, Page 1
[53]
Chaoyun Li, Azadeh Ebrahimi, and Hermann Schluesener
Ageing Research Reviews, 2013, Volume 12, Number 1, Page 116

Comments (0)

Please log in or register to comment.
Log in